NO20043586L - Fremgangsmate for fremstilling av organiske forbindelser - Google Patents
Fremgangsmate for fremstilling av organiske forbindelserInfo
- Publication number
- NO20043586L NO20043586L NO20043586A NO20043586A NO20043586L NO 20043586 L NO20043586 L NO 20043586L NO 20043586 A NO20043586 A NO 20043586A NO 20043586 A NO20043586 A NO 20043586A NO 20043586 L NO20043586 L NO 20043586L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- organic compounds
- compounds
- organic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35231602P | 2002-01-28 | 2002-01-28 | |
| US38318802P | 2002-05-24 | 2002-05-24 | |
| PCT/EP2003/000804 WO2003064382A2 (en) | 2002-01-28 | 2003-01-27 | Process for the manufacture of organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20043586L true NO20043586L (no) | 2004-10-07 |
| NO327363B1 NO327363B1 (no) | 2009-06-15 |
Family
ID=27669055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043586A NO327363B1 (no) | 2002-01-28 | 2004-08-27 | Fremgangsmate for fremstilling av organiske forbindelser |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6835838B2 (no) |
| EP (1) | EP1472227B1 (no) |
| JP (1) | JP2005516064A (no) |
| KR (2) | KR20100091267A (no) |
| CN (2) | CN1625550A (no) |
| AU (4) | AU2003239294B2 (no) |
| BR (1) | BR0307236A (no) |
| CA (1) | CA2472340A1 (no) |
| CO (1) | CO5601045A2 (no) |
| EC (1) | ECSP045202A (no) |
| IL (1) | IL162817A0 (no) |
| MX (1) | MXPA04007308A (no) |
| NO (1) | NO327363B1 (no) |
| NZ (3) | NZ534136A (no) |
| PL (1) | PL371383A1 (no) |
| RU (1) | RU2360903C2 (no) |
| SG (2) | SG161742A1 (no) |
| WO (1) | WO2003064382A2 (no) |
| ZA (1) | ZA200405239B (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1417180B1 (en) | 2001-07-13 | 2006-12-27 | AstraZeneca UK Limited | Preparation of aminopyrimidine compounds |
| KR100919941B1 (ko) * | 2001-11-14 | 2009-10-05 | 닛산 가가쿠 고교 가부시키 가이샤 | 광학활성 옥소헵텐산 에스테르의 제조방법 |
| PT1472228E (pt) * | 2002-01-31 | 2009-06-24 | Novartis Ag | Processo para a produção de inibidores da hmg-coa reductase |
| ZA200502325B (en) * | 2002-09-20 | 2006-11-29 | Nissan Chemical Ind Ltd | Method for producing a 3,5-dihydroxy-6-heptenoate |
| CA2513837A1 (en) * | 2003-02-12 | 2004-08-26 | Paul Adriaan Van Der Schaaf | Crystalline forms of pitavastatin calcium |
| US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| TWI328006B (en) | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
| CN1763015B (zh) * | 2004-10-22 | 2011-06-22 | 四川抗菌素工业研究所有限公司 | 一种罗舒伐他汀及其药用盐的制备方法及中间体 |
| GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
| GB0514078D0 (en) | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
| WO2007125547A2 (en) * | 2006-05-03 | 2007-11-08 | Manne Satyanarayana Reddy | Novel process for statins and its pharmaceutically acceptable salts thereof |
| US8404841B2 (en) * | 2006-10-09 | 2013-03-26 | Msn Laboratories Limited | Process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
| WO2010089770A2 (en) * | 2009-01-19 | 2010-08-12 | Msn Laboratories Limited | Improved process for the preparation of highly pure (3r,5s)-7-[2-cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxy-6(e)-heptenoic acid and pharmaceutically acceptable salts thereof |
| EP2526099B1 (en) | 2010-01-18 | 2016-03-30 | MSN Laboratories Limited | Improved process for the preparation of amide intermediates and their use thereof |
| EP2423195A1 (en) | 2010-07-26 | 2012-02-29 | LEK Pharmaceuticals d.d. | Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| US9034901B2 (en) | 2010-08-25 | 2015-05-19 | Cadila Healthcare Limited | Pitavastatin calcium and process for its preparation |
| EP3178812A1 (en) * | 2010-11-12 | 2017-06-14 | Hetero Research Foundation | Novel polymorphs of pitavastatin calcium |
| WO2012140490A2 (en) | 2011-04-11 | 2012-10-18 | Aurobindo Pharma Limited | Process for preparing quinoline derivative |
| CN103755568B (zh) * | 2013-12-10 | 2015-10-28 | 江西科技师范大学 | IeodomycinA和B立体选择性合成方法 |
| CN113620871A (zh) | 2015-08-05 | 2021-11-09 | 株式会社Api | 生产匹伐他汀钙的方法 |
| CN108976168B (zh) * | 2017-06-02 | 2020-09-25 | 浙江京新药业股份有限公司 | 一种匹伐他汀半钙盐晶型及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3528186B2 (ja) | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| JP3554036B2 (ja) * | 1994-09-06 | 2004-08-11 | 宇部興産株式会社 | 光学活性な７−置換キノリル−３，５−ジヒドロキシ−ヘプト−６−エン酸エステル誘導体の製造方法 |
| KR100919941B1 (ko) * | 2001-11-14 | 2009-10-05 | 닛산 가가쿠 고교 가부시키 가이샤 | 광학활성 옥소헵텐산 에스테르의 제조방법 |
| US8212035B2 (en) * | 2007-02-08 | 2012-07-03 | Aurobindo Pharma Ltd. | Process for preparation of rosuvastatin calcium field of the invention |
-
2003
- 2003-01-24 US US10/350,615 patent/US6835838B2/en not_active Expired - Lifetime
- 2003-01-27 JP JP2003564005A patent/JP2005516064A/ja active Pending
- 2003-01-27 PL PL03371383A patent/PL371383A1/xx unknown
- 2003-01-27 EP EP03734696.2A patent/EP1472227B1/en not_active Expired - Lifetime
- 2003-01-27 KR KR1020107017248A patent/KR20100091267A/ko not_active Application Discontinuation
- 2003-01-27 WO PCT/EP2003/000804 patent/WO2003064382A2/en active Application Filing
- 2003-01-27 CA CA002472340A patent/CA2472340A1/en not_active Abandoned
- 2003-01-27 NZ NZ534136A patent/NZ534136A/en not_active IP Right Cessation
- 2003-01-27 CN CNA038028778A patent/CN1625550A/zh active Pending
- 2003-01-27 CN CNB200510005170XA patent/CN100378081C/zh not_active Expired - Lifetime
- 2003-01-27 SG SG200605094-2A patent/SG161742A1/en unknown
- 2003-01-27 SG SG200605092-6A patent/SG157225A1/en unknown
- 2003-01-27 NZ NZ554366A patent/NZ554366A/en not_active IP Right Cessation
- 2003-01-27 RU RU2004126448/04A patent/RU2360903C2/ru not_active IP Right Cessation
- 2003-01-27 MX MXPA04007308A patent/MXPA04007308A/es active IP Right Grant
- 2003-01-27 AU AU2003239294A patent/AU2003239294B2/en not_active Ceased
- 2003-01-27 IL IL16281703A patent/IL162817A0/xx unknown
- 2003-01-27 NZ NZ554367A patent/NZ554367A/en not_active IP Right Cessation
- 2003-01-27 KR KR10-2004-7011572A patent/KR20040077883A/ko active Search and Examination
- 2003-01-27 BR BR0307236-3A patent/BR0307236A/pt not_active Application Discontinuation
-
2004
- 2004-07-01 ZA ZA2004/05239A patent/ZA200405239B/en unknown
- 2004-07-14 US US10/891,357 patent/US7572917B2/en not_active Expired - Fee Related
- 2004-07-22 EC EC2004005202A patent/ECSP045202A/es unknown
- 2004-08-06 CO CO04076720A patent/CO5601045A2/es not_active Application Discontinuation
- 2004-08-27 NO NO20043586A patent/NO327363B1/no not_active IP Right Cessation
-
2006
- 2006-10-03 AU AU2006225206A patent/AU2006225206B2/en not_active Ceased
- 2006-10-03 AU AU2006225205A patent/AU2006225205B2/en not_active Ceased
-
2009
- 2009-07-02 US US12/497,001 patent/US20090299065A1/en not_active Abandoned
- 2009-08-12 AU AU2009208129A patent/AU2009208129A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043586L (no) | Fremgangsmate for fremstilling av organiske forbindelser | |
| NO20050136D0 (no) | Fremgangsmate for fremstilling av mikropartikler | |
| NO20070753L (no) | Fremgangsmåte for fremstilling av dihydropteridinoner | |
| EG24716A (en) | Combination of organic compounds | |
| GB0222056D0 (en) | Process for the manufacture of organic compounds | |
| GB0212412D0 (en) | Combination of organic compounds | |
| NO20043345L (no) | Fremgangsmate for fremstilling av hydrokarboner | |
| NO20052568D0 (no) | Fremgangsmate for fremstilling av makrolidforbindelse | |
| NO20052158L (no) | Fremgangsmate for fremstilling av en benzimidazolforbindelse. | |
| GB0204129D0 (en) | Process for the manufacture of organic compounds | |
| GB0316546D0 (en) | Process for the manufacture of organic compounds | |
| IS8470A (is) | Notkun lífrænna efnasambanda | |
| IL172629A0 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20033408D0 (no) | Fremgangsmåte for fremstilling av krystallinske nanopartikler | |
| NO20052471D0 (no) | Fremgangsmate for fremstilling av 3-metyltiopropanal. | |
| GB0210234D0 (en) | Process for the manufacture of organic compounds | |
| NO20034003L (no) | Fremgangsmåte for fremstilling av imidazolforbindelser | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| NO20044050L (no) | Fremgangsmate for syntese av chirale N-aryl-piperaziner | |
| NO20034597L (no) | Fremgangsmate for fremstilling av cantaxantin | |
| GB0402262D0 (en) | Process for the manufacture of organic compounds | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| NO20052396D0 (no) | Fremgangsmate for fremstilling av spirolactonforbindelser | |
| NO20052392L (no) | Fremgangsmate for fremstilling av acetylenforbindelser. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |